Di Zhang

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy”.

A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0210

N/A

0DataRank · unranked

44 citations

Zhilin Hou, Kelly E. Aldrich, Lizbeth Lockwood, Aaron L. Odom, Karen T. Liby +1 more

Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice

Scientific Reports(2021)10.1038/s41598-020-79663-7

N/A

0DataRank · unranked

11 citations

Bijay Singh, Jessica A. Moerland, Owen Mitchell, Lizbeth Lockwood, Sarah Carapellucci +3 more

The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer

Scientific Reports(2022)10.1038/s41598-021-04415-0

N/A

0DataRank · unranked

18 citations

Jessica A. Moerland, Ana S. Leal, Di Zhang, Sarah Carapellucci, Beth Lockwood +5 more